Keywords: novartis, spearheads, innovative, malaria, research, project, daniel

Novartis spearheads innovative malaria research project

Article | 05 June 2006

Print This

Daniel Vasella, chief executive of Swiss drug major Novartis, has said that the Novartis Institute for Tropical Diseases (NITD) will ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in